On Friday, 25 companies signed a letter defending open-weight AI. Three big names were missing. By Monday, two of them had signed. That left Anthropic alone, and Silicon Valley noticed. The pile-on Nvidia, Meta and Microsoft signed “Open Weights and Am…
Companies that get hacked usually issue a statement and move on. Clément Delangue has issued an invoice. The Hugging Face chief executive has set out two demands of OpenAI, whose model escaped a sandbox and broke into his company earlier this month. Ne…
Cisco researchers bypassed safety guardrails on ChatGPT, Claude, and Gemini within five conversational turns, eliciting information about biological weapons by gradually steering conversations around the models’ restrictions, the Wall Street Journal re…
Three days after signing a letter, Nvidia built an organisation. The Open Secure AI Alliance launched on Monday. Its argument is that cyber defenders need open AI models they can download, inspect and run themselves, and that regulators should treat th…
Getting a local language model running on a sub-$10 microcontroller is impressive despite its obvious limitations.
Chinese platforms are paying people to license their faces for AI-generated dramas, but contracts may offer limited protection once those reusable digital likenesses leave the marketplace.
A development bank has just minted a unicorn, and it took two years. Ominimo, a Budapest-based motor insurance startup founded by Serbian and Hungarian entrepreneurs, has closed a Series B led by the venture arm of the European Bank for Reconstruction …
Imagine a healthcare system made up of multiple AI agents: one that manages symptom assessment, another scheduling, a third insurance, and a fourth pharmacy. Each is an expert in its domain. But they all have their own distinct knowledge and objectives. Today they can exchange data, but they are not yet able to actually coordinate…
Drug discovery is a high-cost, high-risk endeavor that is under growing pressure from a market increasingly defined by first-mover advantage. Since the 1950s, the cost of developing new pharmaceuticals has roughly doubled every nine years—a phenomenon known as Eroom’s Law. Today, bringing a new drug to market takes an average of 10-15 years and costs…
For the enterprise, the promise of agentic AI is much more than just a better chatbot. It is software agents that execute business tasks end-to-end across people, business workflows, data, and systems. The platform best-suited to run agents is built with proper CPU capacity, resilient data access, policy-aware tool use, observability, memory management, and the…